share_log
Moomoo 24/7 ·  03/28 12:02

Aldeyra Therapeutics Shares Are Trading Higher. The Company Announced the Clinical Development Plan Intended to Enable Resubmission of a New Drug Application for Reproxalap in Dry Eye Disease

Aldeyra Therapeutics的股價正在走高。該公司宣佈了旨在重新提交治療乾眼病的Reproxalap新藥申請的臨床開發計劃

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論